NYMC Faculty Publications
The Effect of Psoriatic Arthritis on Ixekizumab Clinical Outcomes in Moderate-to-Severe Psoriasis Patients: A Post Hoc Analysis
DOI
10.1016/j.jaad.2018.03.008
Journal Title
Journal of the American Academy of Dermatology
First Page
593
Last Page
595
Document Type
Article
Publication Date
September 2018
Department
Dermatology
Keywords
Antibodies, Monoclonal, Humanized, Arthritis, Psoriatic, Dermatologic Agents, Ixekizumab, Psoriasis, biologics, plaque psoriasis, psoriatic arthritis
Disciplines
Medicine and Health Sciences
Recommended Citation
Gottlieb, A. B., Papp, K., Birbara, C., Shuler, C., Burge, R., Erickson, J., Kerr, L., & Mease, P. (2018). The Effect of Psoriatic Arthritis on Ixekizumab Clinical Outcomes in Moderate-to-Severe Psoriasis Patients: A Post Hoc Analysis. Journal of the American Academy of Dermatology, 79 (3), 593-595. https://doi.org/10.1016/j.jaad.2018.03.008